MUMBAI, April 10 (Reuters) - Mankind Pharmaceuticals Pvt Ltd, one of India's top-ten drugmakers by sales, is willing to spend up to 5 billion rupees ($80.30 million) to buy local rivals and is keen on licensing deals with foreign firms, a top official at the firm said.
The company is also exploring buying established brands to expand its domestic footprint, Managing Director Sheetal Arora told Reuters in a phone interview.
07:49 Murdoch's Twenty-First Century Fox Bids $14 Billion For UK's Sky14
02:11 Murdoch Pounces on Sky as Lower Pound Makes Takeover Cheaper8
15:24 Paris Saint-Germain's Serge Aurier named Ivory Coast Player of the Year12
09:49 Intesa to provide bulk of funds to Glencore for Rosneft deal: sources20